Contemporary Resume

Instruct and mentor students in adult primary care RESEARCH AQX-1125-301The Leadership 301 Trial: A 12-week, randomized, multi-center, double-blind, placebo-controlled, 3 arm parallel group, phase 3 trial to evaluate the efficacy and safety of 2 doses of AQX-1125. ................
................